Purchase Order 36C24226P0199
- Not listed
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to the VA's Veterans Integrated Service Network (VISN) 2. The contract is not set aside for any specific business type, and there are no indications of subcontractors....
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a division of the larger Walgreens retail pharmacy chain. The $12,580.72 firm fixed price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to VA facilities. Jynarque is used to treat autosomal dominant polycystic kidney disease. This contract does not have a set-aside designation and is part of...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
- This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to the prime contractor, Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order with a completion date of February 13, 2025. Walgreens Specialty...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...
- Walgreens Specialty Pharmacy, LLC was awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The $12,580.72 contract is to deliver Jynarque 45MG/15MG tablets to Belle Isle, Florida by June 11, 2024. As the prime contractor, Walgreens Specialty Pharmacy will fulfill this order for the specified medication to support healthcare services for veterans within VISN 2. No set aside was used and no...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) tablets to the VA's Veterans Integrated Service Network 2 (VISN 2) facilities. The contract has a ceiling value of $13,242.99 and a period of performance through August 27, 2025. The contract does not...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of Jynarque (tolvaptan) 45/15 mg tablets, a medication used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on December 4, 2025. The contract was awarded on September 4, 2025 and is not...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order contract to Walgreens Specialty Pharmacy, LLC, a for-profit organization, to provide JYNARQUE 45MG/15MG TABLETS. This $12,580.72 contract has a completion date of July 4, 2024 and was awarded on April 4, 2024. The contract is to support healthcare services for veterans at Veterans Integrated Service Network 2 facilities in Belle Isle, FL. No set-aside designation was used, and no...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the supply of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $83,000.32 and a performance period ending on September 30, 2021. The contract is not set aside for any specific business type....
The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Walgreens Specialty Pharmacy, LLC for the supply of Jynarque 45mg-15mg medication, with a ceiling value of $13,242.99. The contract was awarded on December 3, 2025, with an ultimate completion date of January 2, 2026. Performance will take place in Belle Isle, Florida. This is a non-set-aside acquisition, meaning it was open to all qualified vendors in the competitive marketplace. Walgreens Specialty Pharmacy, LLC, a for-profit subsidiary of Walgreens registered in the System for Award Management since 2009, is a specialized pharmaceutical provider focused on delivering complex and rare medications to federal healthcare facilities, particularly the VA system. Jynarque (tolvaptan) is a specialized medication used to treat autosomal dominant polycystic kidney disease. Walgreens Specialty Pharmacy has an established track record supplying this medication and other rare pharmaceuticals to multiple VISN regions across the country through similarly structured firm fixed-price purchase orders, demonstrating its capability to support veteran healthcare services across various medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 12/4/25 |